Increased P Wave Dispersion and Maximum P Wave Duration after Hemodialysis

Annals of Noninvasive Electrocardiology

Volumn 9, Issue 1, 2004, Pages 34-38

  Tezcan, Ugur K ^a   Amasyali, Basri ^d   Can, Ilknur ^b   Aytemir, Kudret ^b,d   Köse, Sedat ^d   Yavuz, Izzet ^c   Kursaklioglu, Hurkan ^d   Işik, Ersoy ^d   Demirtaş, Ertan ^d   Oto, Ali ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

^d NONE

Author keywords

Atrial fibrillation; Hemodialysis; P wave dispersion

Indexed keywords

BICARBONATE; CREATININE; MAGNESIUM; PHOSPHATE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIALYSIS; DISPERSION; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HUMAN; MALE; P WAVE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 10744233595     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2004.91529.x     Document Type: Article

References (24)

1. Vasquez E, Sanchez-Peralez C, Borrego F, et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 2000;140:886-890.
2. Foley RN, Parfrey PS, Kent GM, et al. Long term evolution of cardiomyopathy in dialysis patients. Kidney Int 1998;54:1720-1725.
3. Ansari N, Manis T, Feinfeld DA. Symptomatic atrial arrhythmias in hemodialysis patients. Renal Fail 2001;23:71-76.
4. Fabbian F, Catalano C, Lambertini D, et al. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol 2000;54:234-239.
5. Abbott KC, Trespalacios FC, Taylor AJ, et al. Atrial fibrillation in chronic dialysis patients in the United States: Risk factors for hospitalization and mortality. BMC Nephrology 2003;24(1):1
6. Harnett JD, Foley RN, Kent GM, et al. Congestive heart failure in dialysis patients: Prevalance, incidence, prognosis and risk factors. Kidney Int 1995;47:884-890.
7. Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998;135:733-738.
8. Gialafos JE, Dialveris PE, Gialafos EJ, et al. P wave dispersion: A valuable elctrocardiographic marker for the prediction of paroxysmal lone atrial fibrillation. Ann Noninvasive Electrocardiol 1999;4:39-45.
9. Weber UK, Osswald S, Huber M, et al. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: Is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low dose sotalol. Eur Heart J 1998;19:794-800.
10. Ozer N, Aytemir K, Atalar E, et al. P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000;23:1859-1862.
11. Kose S, Aytemir K, Can I, et al. Detection of hypertrophic cardiomyopathic patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave dispersion. Clin Cardiol 2003;26:431-436.
12. Tukek T, Yildiz P, Akkaya V, et al. Factors associated with the development of atrial fibrillation in COPD patients: The role of P-wave dispersion. Ann Noninvasive Electrocardiol 2002;7:222-227.
13. Aytemir K, Ozer N, Atalar E, et al. P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000;23:1109-1112.
14. Dilaveris PE, Gialafos EJ, Andrikopoulos GK, et al. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 2000;23:352-358.
15. Szabo Z, Kakuk G, Fulop T, et al. Effects of haemodialysis on maximum P wave duration and P wave dispersion. Nephrol Dial Transplant 2002;17:1634-1638.
16. Korzets A, Ori Y, Herman M. Serum potassium levels and atrial fibrillation in haemodialysis patients. Nephrol Dial Transplant 2001;16:1090.
17. Wahr JA, Parks R, Boisvert D. Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter study of Perioperative Ischemia Research Group. JAMA 1999;281:2203-2210.
18. Emara MK, Saadet AM. Transient atrial fibrillation in hypertensive patients with thiazide induced hypokalemia. Postgrad Med J 1986;62:1125-1127.
19. Nordrehaug JE. Malignant arrhythmia in relation to serum potassium in acute myocardial infarction. Am J Cardiol 1985;56:20D-23D.
20. Oakley C. Genesis of arrhythmias in the failing heart and therapeutic implications. Am J Cardiol 1991;67:26C-28C.
21. Josephson ME, Kastor JA, Morganroth J. Electrocardiographic left atrial enlargement: Electrophysiologic, echocardiographic and hemodynamic correlation. Am J Cardiol 1977;39:967-971.
22. Dagdelen S, Toraman F, Karabulut H, et al. The value of P dispersion on predicting atrial fibrillation after coronary artery bypass surgery: Effect of magnesium on P dispersion. Ann Noninvasive Electrocardiol 2002;7:211-218.
23. Kaplan M, Kut MS, Icer UA, et al. Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery. Thorac Cardiovasc Surg 2003;125:344-352.
24. Dilaveris P, Batchvarov V, Gialafos J, et al. Comparison of different methods for manual P wave duration measurement in 12-lead electrocardiograms. Pacing Clin Electrophysiol. 1999;22:1532-1538.